Drug Discovery Solutions

  1. Transient Expression Platform: discoCHO 10/4/2024

    Learn how this transient platform accelerates biologics production, seamlessly transitioning from discovery to stable CHO-K1, ensuring scalability, and reducing risks in manufacturing therapeutic biologics.

  2. in vitro Kill Rate Studies For Antimicrobial Screening 6/13/2025

    Utilize advanced in vitro time kill-rate studies to accurately assess antimicrobial activity, understand drug-microbe interactions, and evaluate the effectiveness of combination therapies.

  3. Cell Line Development Solutions 5/15/2023

    Discover technology that enables a cost-effective, easily implemented cell line development workflow while delivering high productivity pools and cell lines.

  4. Phosphoramidite Chemistry Capabilities For Oligonucleotide Synthesis 6/18/2025

    Accelerate your research and development with high-quality, custom phosphoramidite synthesis backed by decades of proven chemistry and scalable precision.

  5. Specialized Services In Custom Peptide Synthesis (Solution Phase) 5/16/2025

    Our custom peptide synthesis service offers numerous options for synthesis platforms, purity levels, and modifications to meet a variety of research needs.

  6. Use The Right Tools To Improve Cell Lines And Production Yields 5/15/2023

    Learn about antibody production and purification, engineering antibodies for developability, and antibody humanization while also exploring an integrated pipeline that enables the direct application of machine learning tools.

  7. A Fully Integrated Toolbox For Therapeutic Protein Expression

    The GS Xceed® Gene Expression System is a comprehensive toolbox for development of biologics that has been used to develop not only monoclonal antibodies but also a wide variety of new molecular formats.

  8. Early Phase Bioassays And Analytics 6/26/2024

    The development of phase-appropriate, tailored bioassays is crucial. By identifying promising candidates, bioassays streamline the development process, enabling informed decision-making.

  9. Designed For Inhalation: Pulmonary And Nasal Delivery

    Our newly expanded in-house capabilities span clinical and commercial scale manufacturing for DPIs, unit-dose, bi-dose and preserved multi-dose nasal sprays.

  10. Bioengineering Solutions Using A Fully Integrated Ecosystem 5/30/2023

    Find solutions to meet your gene, protein, antibody, or cell line needs using two gene synthesis platforms that enable the design of constructs optimized for maximal expression/yield in your system.